Effect of TNF-α and IL-1β genetic variants on the development of myocardial infarction in Turkish population

Molecular Biology Reports

Volumn 38, Issue 8, 2011, Pages 5453-5457

  Zeybek, Umit ^a   Toptas, Bahar ^a   Karaali, Zeynep Ermis ^b   Kendir, Mehmet ^b   Cakmakoglu, Bedia ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

IL 1 ; Myocardial infarction; RFLP; SNP; TNF

Indexed keywords

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HEART INFARCTION; HEART PROTECTION; HUMAN; INTERLEUKIN 1 BETA GENE; MALE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; TUMOR NECROSIS FACTOR ALPHA GENE; TURKEY (REPUBLIC);

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HAPLOTYPES; HUMANS; INTERLEUKIN-1BETA; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA; TURKEY;

EID: 84855230865     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0701-x     Document Type: Article

References (33)

1. Libby P (2000) Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol 86(8B):3J-8J
2. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340(2):115-126
3. Sprague AH, Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78(6):539-552
4. Kroeger KM, Carville KS, Abraham LJ (1997) The-308 tumor necrosis factor-a promoter polymorphism effects transcription. Mol Immunol 34:391-399 (Pubitemid 27368335)
5. Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323(4):236-241 (Pubitemid 20225044)
6. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK (1993) Tumour necrosis factor alpha in severe congestive cardiac failure. Br Heart J 70:141-143 (Pubitemid 23248028)
7. Ni Y, Zhang J (2009) Association of deoxyribonuclease I genetic polymorphisms with myocardial infarction in Han Chinese. Mol Biol Rep 36:595-601
8. Chen LL, Zhu TB, Yin H, Huang J, Wang LS, Cao KJ, Yang ZJ (2010) Inhibition of MAPK signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through reductionofinflammation. Mol Biol Rep 37(7):3067-3072
9. Ganesan B, Buddhan S, Anandan R, Sivakumar R, Anbin Ezhilan R (2010) Antioxidant defense of betaine against isoprenaline induced myocardial infarction in rats. Mol Biol Rep 37(3): 1319-1327
10. Dinarello CA (1998) Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16(5-6): 457-499 (Pubitemid 28286181)
11. Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM (1996) Interleukin-1beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol 16:1000-1006 (Pubitemid 26266899)
12. Di Giovine FS, Takhsh E, Blakemore AI, Duff GW (1992) Single base polymorphism at-511 in the human interleukin-1 b gene (IL1 b). Hum Mol Genet 1:450
13. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J (1992) A TaqI polymorphism in the human interleukin-1b (IL-1b) gene correlates with IL-1b secretion in vitro. Eur J Clin Invest 22:396-402
14. WHO (Report of the joint International Society, Federation of cardiology/World Health Organization Task Force on standardization of clinical nomenclature) (1979) Nomenclature and criteria for diagnosis of ischemic heart disaese. Circulation 59:607-609
15. Miller SA, Dykes DD, Polesky HS (1988) Simples salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16(3):1215
16. Treszl A, Toth-Heyn P, Kocsis I, Nobilis A, Schuler A, Tulassay T, Vasarhely B (1992) Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol 17: 713-717
17. Wilson AG, di Giovine FS, Blakemore AI, Duff GW (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by Nco I restriction of PCR product. Hum Mol Genet 1(5):353
18. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265 (Pubitemid 40202029)
19. Bazzoni F, Beutler B (1996) The tumor necrosis factor ligand and receptor families. N Engl J Med 334(26):1717-1725 (Pubitemid 26193625)
20. Wilson AG, di Giovine FS, Duff GW (1995) Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J Inflamm 45(1):1-12
21. Attar R, Agachan B, Kucukhuseyin O, Toptas B, Attar E, Isbir T (2010) Association of interleukin 1beta gene (+3953) polymorphism and severity of endometriosis in Turkish women. Mol Biol Rep 37(1):369-374
22. Zhan P, Wang J, Wei SZ (2010) TNF-308 gene polymorphism is associated with COPD risk among Asians: meta-analysis of data for 6,118 subjects. Mol Biol Rep. doi:10.1007/s11033-010-0098-y
23. Alikasifoglu M, Tokgözoglu L, Acil T, Atalar E, Ali Oto M, Sirri Kes S, Tuncbilek E (2003) Tumor necrosis factor-alpha polymorphism in Turkish patients with dilated cardiomyopathy. Eur J Heart Fail 5(2):161-163 (Pubitemid 36383623)
24. Hou L, Huang J, Lu X, Wang L, Fan Z, Gu D (2009) Polymorphisms of tumor necrosis factor alpha gene and coronary heart disease in a Chinese Han population: interaction with cigarette smoking. Thromb Res 123(6):822-826
25. Biondi-Zoccai GG, Baldi A, Biasucci LM, Abbate (2004) A Female gender, myocardial remodeling and cardiac failure are women protected from increased myocardiocyte apoptosis? Ital Heart J 5(7):498-504
26. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S, Interheart Study Investigators (2006) Tobacco use and risk of myocardial infarction in 52 countries in the Interheart study: a case-control study. Lancet 368(9536):647-658 (Pubitemid 44223693)
27. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, Cambien F (1998) Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 28(1):59-66 (Pubitemid 28062480)
28. Szalai C, Fust G, Duba J, Kramer J, Romics L, Prohaszka. Horvath L, Csaszar A (2002) Association of polymorphisms and allelic combinations in the tumour necrosis factor-a complement MHC region with coronary artery disease. J Med Genet 39(1): 46-51 (Pubitemid 34093606)
29. Allen RA, Lee EM, Roberts DH, Park BK, Pirmohamed M (2001) Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease. Eur J Clin Invest 31(10):843-851 (Pubitemid 34592083)
30. Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, Bardaji A, Ricart W, Richart C (2003) A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 167(2):257-264 (Pubitemid 36773525)
31. Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Frostegard J, Wiman B, Prince JA, Faire U (2006) Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis 187(2):408-414 (Pubitemid 43963023)
32. Appoloni O, Dupont E, Vandercruys M, Andrien M, Duchateau J, Vincent JL (2004) Association between the TNF-2 allele and a better survival in cardiogenic shock. Chest 125(6):2232-2237 (Pubitemid 38788194)
33. Abraham LJ, Kroeger KM (1999) Impact of the-308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66(4):562-566 (Pubitemid 29489880)